Clinical Trial Detail

NCT ID NCT03319901
Title Venetoclax and Chemotherapy In ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphocytic leukemia

Therapies

Cytarabine

Mercaptopurine

Methotrexate

Cyclophosphamide

Venetoclax

Doxorubicin

Etoposide

Vincristine

Age Groups: adult senior

No variant requirements are available.